SCHEMBL723217

SCHEMBL723217

C=Cc1ccc(C(=O)ON2C(=O)CCC2=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
HPGD P15428 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
KMT2A Q03164 4/20 0.34
TAS1R3 Q7RTX0 3/20 0.34
TAS1R1 Q7RTX1 3/20 0.34
MGLL Q99685 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
PIM1 P11309 1/20 0.33
SNCA P37840 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL300884 0.86 CA12 (0.42) ALDH1A1HPGDCA12CA1CA9
SCHEMBL43877 0.85 ALDH1A1 (0.51) ALDH1A1HPGDCA12CA1CA9
SCHEMBL18530063 0.84 ALDH1A1 (0.50) ALDH1A1HPGDCA12CA1CA9
SCHEMBL9554693 0.83 PTPN1 (0.35) ALDH1A1HPGDCA12CA1CA9
SCHEMBL21160109 0.82 MAPK1 (0.40) ALDH1A1KMT2AMGLLTDP1MAPK1
SCHEMBL16005095 0.81 ALDH1A1 (0.37) ALDH1A1HPGDCA12CA1CA9
SCHEMBL22046417 0.81 F3 (0.44) ALDH1A1HPGDCA12CA1CA9
SCHEMBL13455758 0.81 SMN1; SMN2 (0.44) ALDH1A1HPGDCA12CA1CA9
SCHEMBL14156433 0.80 L3MBTL1 (0.40) ALDH1A1HPGDKMT2ATDP1SNCA
SCHEMBL9626036 0.80 GRIN2D (0.38) ALDH1A1CA1KMT2AKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112812228-B UCST enhanced acrylamide copolymer and preparation method thereof 中国医学科学院生物医学工程研究所 2024-06-25 CN disclosed
WO-2016183359-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. (US) 2016-11-17 WO disclosed
US-9206271-B2 Fully backbone degradable and functionalizable polymers derived from the ring-opening metathesis polymerization (ROMP) WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-12-08 US disclosed
US-9206271-B2 Fully backbone degradable and functionalizable polymers derived from the ring-opening metathesis polymerization (ROMP) WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-12-08 US disclosed
US-20130281644-A1 Fully Backbone Degradable and Functionalizable Polymers Derived from the Ring-Opening Metathesis Polymerization (ROMP) WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-10-24 US disclosed
US-8426649-B2 Cyclopropenones and the photochemical generation of cyclic alkynes therefrom UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2013-04-23 US disclosed
US-20120053299-A1 Cyclopropenones and the Photochemical Generation of Cyclic Alkynes Therefrom UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053299-A1 Cyclopropenones and the Photochemical Generation of Cyclic Alkynes Therefrom WEE1, WEE2, MPI ALDH1A1 205/4885HPGD 508/4885CA12 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.